146 related articles for article (PubMed ID: 8596149)
1. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
McMurray RW; Weidensaul D; Allen SH; Walker SE
J Rheumatol; 1995 Nov; 22(11):2084-91. PubMed ID: 8596149
[TBL] [Abstract][Full Text] [Related]
2. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR
J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study.
Alvarez-Nemegyei J; Cobarrubias-Cobos A; Escalante-Triay F; Sosa-Muñoz J; Miranda JM; Jara LJ
Lupus; 1998; 7(6):414-9. PubMed ID: 9736326
[TBL] [Abstract][Full Text] [Related]
4. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH
Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
[TBL] [Abstract][Full Text] [Related]
5. Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine.
Walker SE; Smarr KL; Parker JC; Weidensaul DN; Nelson W; McMurray RW
Lupus; 2000; 9(7):527-33. PubMed ID: 11035419
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
8. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
Reuman PD
Arthritis Rheum; 2004 Nov; 50(11):3616-8. PubMed ID: 15529390
[TBL] [Abstract][Full Text] [Related]
9. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
[TBL] [Abstract][Full Text] [Related]
10. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Pochopień-Kenig G; Scieszka J
Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
[TBL] [Abstract][Full Text] [Related]
11. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
Chang DM; Lan JL; Lin HY; Luo SF
Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
[TBL] [Abstract][Full Text] [Related]
13. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial.
Jara LJ; Cruz-Cruz P; Saavedra MA; Medina G; García-Flores A; Angeles U; Miranda-Limón JM
Ann N Y Acad Sci; 2007 Sep; 1110():297-304. PubMed ID: 17911444
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
[TBL] [Abstract][Full Text] [Related]
17. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC
Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263
[TBL] [Abstract][Full Text] [Related]
18. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
El-Garf A; Salah S; Shaarawy M; Zaki S; Anwer S
J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus.
Polderman MC; le Cessie S; Huizinga TW; Pavel S
Rheumatology (Oxford); 2004 Nov; 43(11):1402-4. PubMed ID: 15304672
[TBL] [Abstract][Full Text] [Related]
20. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
